Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/124

Result Summary for 101468/124

Result Summary

Protocol ID:	101468/124
Clinical Study ID:	101468/124
Official Title:	Open, Bromocriptine controlled study of Ropinirole at a flexible oral dose of 0.25-3.0mg T.I.D. in the treatment of Parkinsonian patients not optimally controlled on L-Dopa (DCI)
Phase:	Phase 3
Study Indications or Diseases:	Parkinson Disease
Generic Name:	ropinirole
Trade/Product Name:	requip;requip
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Im JH, Ha JH, Cho IS, Lee MC, Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study. J Neurol. 2003 Jan;250(1):90-6.